The 2019-2020 Cyto-econference Webinar Series Continues……..

October 22, 2019   

Andre I. Moreira, MD, PhD

Anjali Saqi, MD, MBA

Anjali Saqi, MD, MBA
Columbia University Medical Center
New York, New York

Andre I. Moreira, MD, PhD
New York University Langone Health
New York, New York

Small biopsy and cytology specimens are often the only available specimen for diagnosis and determination of prognostic and predictive markers in lung cancer. Despite several diagnostic categories available for resected specimen, cytological diagnosis is restricted to adenocarcinoma, squamous cell carcinoma and neuroendocrine tumors. Diagnostic criteria and use of ancillary tests for tumor classification will be discussed. Tumors of the mediastinum are rare and the site can be involved in many different tumors. Most pathologists are not familiar with mediastinal disease, especially cytological features of these entities. In this webinar, we will discuss a cytologic diagnostic approach for mediastinal diseases.

View More

The 2019-2020 Cyto-econference Webinar Series Begins........
Click Here!